Clinical trial
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness…
NCT00295139 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00295139 |
|---|---|
| Title | Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients |
| Official title | Behavioral Treatment of Drug Abuse in SPMI Patients |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Mood Disorders, Substance Dependence |
| Intervention type | Behavioral |
| Interventions | Behavioral Treatment for Substance Abuse in SPMI (BTSAS), Supportive Treatment in Addiction Recovery (STAR), Critical Time Intervention (CTI) |
| Enrollment | 293 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Feb 22, 2006 |
| Last update posted | Feb 18, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: